Podcasts360

In this podcast, William Schaffner, MD, talks about updates from the June 2021 Advisory Committee on Immunization Practices (ACIP), including recommendations for influenza vaccine, pneumococcal vaccines for adults, herpes zoster vaccine, dengue vaccine, and rabies vaccine.

In this podcast, Sarah Bolander, DMSc, PA-C, discusses appropriately identifying and describing common eponymous extremity fractures in a primary care setting. For more, visit www.consultant360.com

In this podcast, Dr Volkmann, director of the UCLA Scleroderma Program and the founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program, discusses treatment and monitoring of patients with systemic sclerosis-related ILD.

In this podcast, William Schaffner, MD, offers tips for clinicians on communicating information to their patients regarding COVID-19 and the COVID-19 vaccines, including dispelling misinformation about the COVID-19 vaccines.

In this podcast, Chuck Vega, MD speaks about the financial implications of various treatments for patients with community-acquired bacterial pneumonia (CABP) and for the care system. He also speaks about the decision of inpatient vs outpatient care. This podcast is part 3 of a 3-part series on managing CABP.

In this podcast, Chuck Vega, MD, speaks about how clinicians determine site and duration of treatment for community-acquired bacterial pneumonia (CABP) based on patients' factors and prior treatment, including the difference in score systems used to predict the severity of CABP and the considerations for inpatient vs outpatient care. This podcast is part 2 of a 3-part series on managing CABP.

In this podcast, Chuck Vega, MD, speaks about how to treat patients with community-acquired bacterial pneumonia (CABP) and how it is managed for the most common presentations, including the typical bacterial pathogens that cause CABP, the most common symptoms, treatment guidelines, and standard workup of CABP.

In this podcast, Forest Arnold, MD, and Michael Egger, MD, speak about their study that aimed to evaluate the cost-effectiveness of adhering to treatment guidelines for community-acquired bacterial pneumonia in elderly patients who are hospitalized, including how the results of their study will impact clinical practice going forward.

In this podcast, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers, a topic she recently presented at the 2021 American Academy of Physician Assistants Annual Conference. For more, visit www.consultant360.com

In this first podcast of a series, Dr Birnbaum, chief of rheumatology at California Pacific Medical Center in San Francisco, gives an overview of lupus nephritis and discusses the diagnosis, treatment, and challenges of this complication of systemic lupus erythematosus.

In this podcast, Andrea Cox, MD, PhD, discusses her team’s recent randomized controlled trial that examined the effectiveness of a vaccine regimen for preventing chronic hepatitis C virus infection. For more, visit www.consultant360.com

In this podcast, rheumatologists and research scientists Jeffrey Sparks, MD, and Zachary Wallace, MD, discuss the findings of their research into the outcomes of patients with rheumatoid arthritis taking DMARDs at baseline who contracted COVID-19.

At the Advances in Inflammatory Bowel Diseases regional meeting on June 19, Dr Wang, from the MD Anderson Cancer Center in Houston, Texas, discussed the management of colitis among patients receiving immune checkpoint inhibitor therapy for cancer.

In the second podcast of a 2-part discussion, Dr Sammaritano discusses the challenges of caring for patients with lupus nephritis during pregnancy, including the safe medications to use and how to manage flares of disease.

In this podcast, Drs Brian Lacy and David Cangemi of the Mayo Clinic in Jacksonville, and Dr Kenneth Koch of Wake Forest Medical School, discuss the intricacies of diagnosing and differentiating functional dyspepsia and gastroparesis.

In this podcast, Vikas Majithia, MD, an associate professor of medicine, director of the Division of Rheumatology and the rheumatology fellowship program director at the University of Mississippi Medical Center (UMMC), discusses the diagnosis of lupus nephritis and how precise classification of the stage of disease can optimize treatment decisions.

In this podcast, Rajesh Gandhi, MD, talks about what you should know about COVID-19 vaccines for your patients with HIV, including whether COVID-19 vaccines are safe for people with HIV, how managing patients with HIV has changed during the COVID-19 pandemic, and what research still needs to be done on COVID-19 vaccines and patients with HIV. He also presented on this topic at the annual ACT HIV 2...

In this podcast, Paul Y. Kwo, MD talks about his research that investigated different strategies for treating chronic hepatitis C virus (HCV), as well as why he believes the diagnosis of HVC and treatment of patients with HCV need to be decentralized.

In this podcast, Michelle M. Cloutier, MD, talks about the report from The National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) on the 2020 focused updates to asthma management guidelines, including 6 prespecified topics and 19 recommendations in the 6 topic areas. She also presented on this topic at the annual American Thoracic Society 2021 annual meeting.

In this podcast, William Schaffner, MD, speaks about the research being done on a universal influenza vaccine that would protect against a variety of different strains of influenza. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.

In this soundbite, William Schaffner, MD, speaks about whether concomitant receipt of recombinant zoster vaccine with another vaccine increases the risk of herpes zoster compared with receiving recombinant zoster vaccine alone. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.

In this soundbite, William Schaffner, MD, speaks about the crucial need that exists with current hepatitis B virus vaccination strategies for enhancing immunogenicity in older adults and those with comorbidities. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.

In this soundbite, William Schaffner, MD, speaks the need for a safe and effective vaccine against cytomegalovirus infection to prevent congenital cytomegalovirus, including the potential of using a messenger RNA vaccine. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.

In this soundbite, William Schaffner, MD, speaks about what research on school-required immunizations says about the likelihood that parents would allow children to receive a COVID-19 vaccine, even if it is considered safe and effective for children. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.

In this soundbite, William Schaffner, MD, speaks about the differences in COVID-19 vaccination intent and factors that affect COVID-19 vaccination acceptance, including what is being done to bridge gaps and encourage uptake in the Black population. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.